Suchergebnisse - Portal für Medizinische Datenmodelle (MDM-Portal)

transition dyspnoea index salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470

- 16.08.17 - 1 Formular, 2 Itemgruppen, 4 Datenelemente, 1 Sprache

Itemgruppen: administrative data, transition dyspnoea index

Study ID: 100470 Clinical Study ID: SCO100470 Study Title: A multicentre, randomised, double-blind, parallel group, 24 week study to compare the effect of salmeterol/fluticasone propionate combination product 50/250mcg, with salmeterol 50mcg both delivered twice daily via DISKUS®/ACCUHALER® inhaler on lung function and dyspnoea in subjects with Chronic Obstructive Pulmonary Disease (COPD). Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor:GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: fluticasone propionate/salmeterol Trade Name: Serevent Study Indication: Pulmonary Disease, Chronic Obstructive

baseline dyspnoea index salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470

- 08.08.17 - 1 Formular, 11 Itemgruppen, 28 Datenelemente, 1 Sprache

Itemgruppen: administrative data, baseline dyspnoea index, job, housework, shopping, leisure activities, gardening, social participation, washing, dressing, at rest, other aspect, baseline dyspnoea index score, date

Study ID: 100470 Clinical Study ID: SCO100470 Study Title: A multicentre, randomised, double-blind, parallel group, 24 week study to compare the effect of salmeterol/fluticasone propionate combination product 50/250mcg, with salmeterol 50mcg both delivered twice daily via DISKUS®/ACCUHALER® inhaler on lung function and dyspnoea in subjects with Chronic Obstructive Pulmonary Disease (COPD). Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor:GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: fluticasone propionate/salmeterol Trade Name: Serevent Study Indication: Pulmonary Disease, Chronic Obstructive

visit 1 (medical evaluation) salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470

- 08.08.17 - 1 Formular, 17 Itemgruppen, 47 Datenelemente, 1 Sprache

Itemgruppen: administrative data, demography, medical condition, tobacco use, COPD, oropharyngeal candidasis examination, Chest x-ray, modified medical research council dyspnoea scale, 12-lead ECG, pulmonary function testing, pulmonary funtion testing: FEV1, pulmonary function testing: FVC, pulmonary function testing: FEV1 /FVC ratio, fat free mass, laboratory blood, St. George's respiratory questionnaire, baseline dyspnoea index

Study ID: 100470 Clinical Study ID: SCO100470 Study Title: A multicentre, randomised, double-blind, parallel group, 24 week study to compare the effect of salmeterol/fluticasone propionate combination product 50/250mcg, with salmeterol 50mcg both delivered twice daily via DISKUS®/ACCUHALER® inhaler on lung function and dyspnoea in subjects with Chronic Obstructive Pulmonary Disease (COPD). Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor:GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: fluticasone propionate/salmeterol Trade Name: Serevent Study Indication: Pulmonary Disease, Chronic Obstructive

clinic internal medicine B SHIP-Trend-1 operational data lung function

- 24.01.21 - 1 Formular, 1 Itemgruppe, 58 Datenelemente, 2 Sprachen

Itemgruppe: operational data lung function

operational data lung function form of SHIP Study (Study of Health in Pomerania), conducted by the University Medicine of Greifswald. SHIP unique domain name TREND.TREND1.IMB.LUF.LUFOPD. ODM derived from https://www.fvcm.med.uni-greifswald.de/dd_service/data_use_explore.php. Further information: http://www2.medizin.uni-greifswald.de/cm/fv/ship.html. Publication granted by Prof. Völzke. Reference: Völzke H, et al. Cohort profile: the study of health in Pomerania. Int J Epidemiol. 2011;40(2):294-307. PMID: 20167617

Ewing Study Organ function prior to high dose chemo DRKS00003588 - Organ function prior to high dose chemo

- 04.08.14 - 1 Formular, 6 Itemgruppen, 14 Datenelemente, 2 Sprachen

Itemgruppen: Show identification of patient, Cardiac function, Glomerular filtration, Tubular function, Liver function, Lung function

EWING 2008, EudraCT 2008-003658-13, http://clinicaltrials.gov/ct2/show/NCT00824083

Stichworte

Inhaltsverzeichnis

Ausgewählte Datenmodelle

transition dyspnoea index salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470

baseline dyspnoea index salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470

visit 1 (medical evaluation) salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470

clinic internal medicine B SHIP-Trend-1 operational data lung function

Ewing Study Organ function prior to high dose chemo DRKS00003588 - Organ function prior to high dose chemo

Stichworte

Inhaltsverzeichnis

Ausgewählte Datenmodelle

transition dyspnoea index salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470

baseline dyspnoea index salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470

visit 1 (medical evaluation) salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470

clinic internal medicine B SHIP-Trend-1 operational data lung function

Ewing Study Organ function prior to high dose chemo DRKS00003588 - Organ function prior to high dose chemo

Kontakt

Hilfe